Pasar al contenido principal

INNOVACION, DESARROLLO Y MEJORA DE LOS TRATAMIENTOS PERSONALIZADOS DE RADIOTERAPIA

PID2021-125096NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 14
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Eines computacionals avançades per a planificació radioterapèutica mitjançat simulacions Monte Carlo

  • Oliver-Gil, Sandra|||0000-0001-8258-3972
[ES] La tesi presentada a aquest document, s'emmarca dins de l'àmbit de la física mèdica. Dins d'aquesta branca de la física, es desenvolupen eines computacionals per oferir millores en la planificació de tractaments que involucren radiació ionitzant. En aquestes planificacions, es calculen factors dosimètrics com la dosi total absorbida tant, a la regió d'interès del tractaments, objectiu del mateix, com a la resta de teixits o òrgans de risc propers a la zona objectiu. Per poder efectuar aquests càlculs, existeixen diferents tècniques, sent les simulacions basades en Monte Carlo les considerades com l'eina més precisa. Aquest tipus de simulacions, permeten modelitzar els dispositius mèdics que emeten el feix de tractament als pacients, de forma detallada. A més, les simulacions Monte Carlo, permeten descriure les fonts de radiació minuciosament i considerar el transport de les partícules involucrades en el problema a través de la geometria considerada. En els treballs que conformen aquesta tesi, s'han emprat diferents codis Monte Carlo, depenent del problema a dur a terme. S'ha emprat MCNP6 a diferents treballs per la capacitat, i facilitat, de modelar geometries complexes emprant mallats volumètriques, penEasy com a codi per validar algunes de les eines dissenyades i penRed, per les característiques especialitzades en física mèdica, com la lectura i processament automàtic de DICOM i les fonts de braquiteràpia, el que faciliten molt les simulacions en l'entorn mèdic. Degut a estos fets, i a que penRed, és de codi obert i no requereix llicència, com al cas del MCNP, s'ha decidit estendre les capacitats que manquen en este, per poder equiparar el seu ús a la resta de codis en els problemes abordats durant la realització de la tesi doctoral. Tots aquests treballs contribueixen al desenvolupament d'eines que, mitjançant la simulació Monte Carlo, permeten optimitzar els càlculs en radioteràpia. Més encara, les eines desenvolupades, tenen una aplicabilitat més general i poden emprar-se en altres camps o problemes, com, per exemple, diagnòstic basat en imatge mèdica. El primer dels treballs, cobreix la necessita del codi MCNP6 de ser capaç de llegir i escriure fitxers d'espai de fase en format estàndard de la IAEA, eina que ja tenen implementadas molts dels codis de simulació Monte Carlo. Per suplir la manca de MCNP6 d'aquesta capacitat, es desenvolupa en aquesta tesi un codi capaç de realitzar aquestes conversions entre format d'espai de fase intern de MCNP6 i formats IAEA i a l'inrevés. Al segon treball, s'empren simulacions Monte Carlo per tal de dissenyar un filtre que homogeinitze el feix d'electrons de 12 MeV a l'eixida d'un accelerador de radioteràpia intraoperàtoria. El treball proporciona una configuració de filtre, dissenyada amb simulació Monte Carlo i validada amb altre grup d'investigació independent. El tercer treball, es basa en oferir una millora als elevats temps de computació a l'hora de realitzar planificacions de radioteràpia amb simulacions Monte Carlo per a tractaments amb diferents irradiacions angulars. Amb aquesta eina es pretén agilitzar significativament el procés de càlcul de distribució de dosi en el maniquí o pacient, sense haver de realitzar la simulació a través de tots els components de l'accelerador. Finalment, arrel d'haver emprat geometries basades en malles en les simulacions realitzades amb MCNP6, s'ha vist la importància d'aquesta capacitat, especialment en simulacions en l'àmbit de la física mèdica. La definició de geometries per descriure el sistema, és una part fonamental de qualsevol simulació, independentment del codi que s'utilitza per a dur-la a terme. És per això que, el quart treball, es centra en el desenvolupament d'un mòdul per a simular sobre geometries mallades en penRed., [CA] La tesis presentada en este documento se enmarca dentro del ámbito de la física médica. Dentro de esta rama de la física, se desarrollan herramientas computacionales para ofrecer mejoras en la planificación de tratamientos que involucran radiación ionizante. En estas planificaciones, se calculan factores dosimétricos como la dosis total absorbida tanto en la región de interés del tratamiento, objetivo del mismo, como en el resto de tejidos u órganos de riesgo cercanos a la zona objetivo. Para poder llevar a cabo estos cálculos, existen diferentes técnicas, siendo las simulaciones basadas en Monte Carlo consideradas como la herramienta más precisa. Este tipo de simulaciones permiten modelar los dispositivos médicos que emiten el haz de tratamiento a los pacientes de forma detallada. Además, las simulaciones Monte Carlo permiten describir las fuentes de radiación minuciosamente y considerar el transporte de las partículas involucradas en el problema a través de la geometría considerada. En los trabajos que conforman esta tesis, se han empleado diferentes códigos Monte Carlo, dependiendo del problema a abordar. Se ha utilizado MCNP6 en diferentes trabajos por su capacidad y facilidad para modelar geometrías complejas utilizando mallas volumétricas, penEasy como código para validar algunas de las herramientas diseñadas y penRed, por sus características especializadas en física médica, como la lectura y procesamiento automático de DICOM y las fuentes de braquiterapia, lo que facilita mucho las simulaciones en el entorno médico. Debido a estos hechos, y a que penRed es de código abierto y no requiere licencia, como es el caso de MCNP, se ha decidido ampliar las capacidades que faltan en este, para poder equiparar su uso al resto de códigos en los problemas abordados durante la realización de la tesis doctoral. Todos estos trabajos contribuyen al desarrollo de herramientas que, mediante la simulación Monte Carlo, permiten optimizar los cálculos en radioterapia. Además, las herramientas desarrolladas tienen una aplicabilidad más general y pueden emplearse en otros campos o problemas, como por ejemplo, el diagnóstico basado en imagen médica. El primero de los trabajos cubre la necesidad del código MCNP6 de ser capaz de leer y escribir archivos de espacio de fase en formato estándar de la IAEA, herramienta que ya tienen implementadas muchos de los códigos de simulación Monte Carlo. Para suplir la falta de MCNP6 de esta capacidad, se desarrolla en esta tesis un código capaz de realizar estas conversiones entre formato de espacio de fase interno de MCNP6 y formatos IAEA y viceversa. En el segundo trabajo, se emplean simulaciones Monte Carlo para diseñar un filtro que homogenice el haz de electrones de 12 MeV en la salida de un acelerador de radioterapia intraoperatoria. El trabajo proporciona una configuración de filtro, diseñada con simulación Monte Carlo y validada con otro grupo de investigación independiente. El tercer trabajo se basa en ofrecer una mejora a los elevados tiempos de computación al realizar planificaciones de radioterapia con simulaciones Monte Carlo para tratamientos con diferentes irradiaciones angulares. Con esta herramienta se pretende agilizar significativamente el proceso de cálculo de distribución de dosis en el maniquí o paciente, sin tener que realizar la simulación a través de todos los componentes del acelerador. Finalmente, a raíz de haber empleado geometrías basadas en mallas en las simulaciones realizadas con MCNP6, se ha visto la importancia de esta capacidad, especialmente en simulaciones en el ámbito de la física médica. La definición de geometrías para describir el sistema es una parte fundamental de cualquier simulación, independientemente del código que se utilice para llevarla a cabo. Es por ello que el cuarto trabajo se centra en el desarrollo de un módulo para simular sobre geometrías malladas en penRed., [EN] The thesis presented in this document falls within the scope of medical physics. Within this branch of physics, computational tools are developed to offer improvements in the planning of treatments involving ionizing radiation. In these plans, dosimetric factors are calculated, such as the total absorbed dose both in the region of interest of the treatment, which is the treatment's objective, and in the surrounding tissues or organs at risk near the target area. To perform these calculations, different techniques exist, with Monte Carlo simulations considered the most accurate tool. These simulations allow modeling of medical devices emitting the treatment beam to patients in detail. Furthermore, Monte Carlo simulations enable a detailed description of radiation sources and consider the transport of particles involved in the problem through the considered geometry. Different Monte Carlo codes have been used in the works comprising this thesis, depending on the problem addressed. MCNP6 has been used in various works for its capacity and ease in modeling complex geometries using volumetric meshes, penEasy as a code to validate some of the designed tools, and penRed for its specialized features in medical physics, such as reading and automatic processing of DICOM and brachytherapy sources, greatly facilitating simulations in the medical environment. Due to these facts, and because penRed is open-source and does not require a license, unlike MCNP, it has been decided to expand its capabilities to match its use with other codes in the problems addressed during the completion of the doctoral thesis. All of these works contribute to the development of tools that, through Monte Carlo simulation, optimize calculations in radiotherapy. Additionally, the developed tools have broader applicability and can be used in other fields or problems, such as diagnosis based on medical imaging. The first of the works covers the need for the MCNP6 code to be able to read and write phase space files in the standard IAEA format, a tool that many Monte Carlo simulation codes already have implemented. To address the lack of this capability in MCNP6, a code capable of performing these conversions between the internal phase space format of MCNP6 and IAEA formats, and vice versa, is developed in this thesis. In the second work, Monte Carlo simulations are used to design a filter that homogenizes the 12 MeV electron beam at the output of an intraoperative radiotherapy accelerator. The work provides a filter configuration, designed with Monte Carlo simulation and validated with another independent research group. The third work aims to improve the high computation times when performing radiotherapy planning with Monte Carlo simulations for treatments with different angular irradiations. This tool aims to significantly speed up the process of dose distribution calculation in the phantom or patient, without having to simulate through all components of the accelerator. Finally, due to having employed mesh-based geometries in simulations conducted with MCNP6, the importance of this capability has been recognized, especially in simulations in the field of medical physics. The definition of geometries to describe the system is a fundamental part of any simulation, regardless of the code used to perform it. Therefore, the fourth work focuses on the development of a module to simulate on meshed geometries in penRed., This study was supported by the program “Ayudas para la promoción de empleo joven e implantación de la Garantía Juvenil en I+D+i, Plan Estatal de Investigación Científica y Técnica e Innovación 2017-2020” from the “Iniciativa de Empleo Juvenil” (IEJ) and the “Fondo Social Europeo” (FSE) We would like to acknowledge the Spanish “Ministerio de Ciencia e Innovación” (MCIN) grant PID2021-125096NB-I00 funded by MCIN/AEI/10.13039 and the “Generalitat Valenciana” (GVA) grant PROMETEO/2021/064.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Benchmark of the PenRed Monte Carlo framework for HDR brachytherapy

  • Oliver-Gil, Sandra|||0000-0001-8258-3972
  • Giménez-Alventosa, Vicent|||0000-0003-1646-6094
  • Berumen, F.
  • Giménez, V.
  • Beaulieu, L.
  • Ballester, F.
  • Vijande, J.
[EN] Purpose: The purpose of this study is to validate the PenRed Monte Carlo framework for clinical applications in brachytherapy. PenRed is a C++ version of Penelope Monte Carlo code with additional tallies and utilities. Methods and materials: Six benchmarking scenarios are explored to validate the use of PenRed and its improved bachytherapy-oriented capabilities for HDR brachytherapy. A new tally allowing the evaluation of collisional kerma for any material using the track length kerma estimator and the possibility to obtain the seed positions, weights and directions processing directly the DICOM file are now implemented in the PenRed distribution. The four non-clinical test cases developed by the Joint AAPM-ESTRO-ABG-ABS WG-DCAB were evaluated by comparing local and global absorbed dose differences with respect to established reference datasets. A prostate and a palliative lung cases, were also studied. For them, absorbed dose ratios, global absorbed dose differences, and cumulative dose-volume histograms were obtained and discussed. Results: The air-kerma strength and the dose rate constant corresponding to the two sources agree with the reference datatests within 0.3% (Sk) and 0.1% (¿). With respect to the first three WG-DCAB test cases, more than 99.8% of the voxels present local (global) differences within ±1%(±0.1%) of the reference datasets. For test Case 4 reference dataset, more than 94.9%(97.5%) of voxels show an agreement within ±1%(±0.1%), better than similar benchmarking calculations in the literature. The track length kerma estimator scorer implemented increases the numerical efficiency of brachytherapy calculations two orders of magnitude, while the specific brachytherapy source allows the user to avoid the use of error-prone intermediate steps to translate the DICOM information into the simulation. In both clinical cases, only minor absorbed dose differences arise in the low-dose isodoses. 99.8% and 100% of the voxels have a global absorbed dose difference ratio within ±0.2% for the prostate and lung cases, respectively. The role played by the different segmentation and composition material in the bone structures was discussed, obtaining negligible absorbed dose differences. Dose-volume histograms were in agreement with the reference data. Conclusions: PenRed incorporates new tallies and utilities and has been validated for its use for detailed and precise high-dose-rate brachytherapy simulations., This work is partially supported by the Ministerio de Ciencia e Innovación of Spain (MCIN) grants PID2020- 113126RB-I00 and PID2021-125096NB-I00 funded by MCIN/AEI/10.13039/501100011033. V. G. acknowledges partial support from AEI-MICINN under grant PID2020-1 13334GB-I00/AEI/10.13039/501100011033 and by Generalitat Valenciana through the project PROMETEO/2019/087. The work has also been supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) grant RGPIN-2019-05038. Francisco Berumen acknowledges support by the Fonds de Recherche du Québec ¿ Nature et Technologies (FRQNT). J.V. and F.B. would like to acknowledge funding by MCIN/ AEI/10.13039 and the Generalitat Valenciana (GVA) grant PROMETEO/2021/064. Our colleague Prof. Vicent Giménez Gómez passed away on November 16, 2022, during the proofs of this study. We dedicate it to his memory. The Universitat de València lost a dedicated and accomplished physicist.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Generation of 3D reference dosimetric datasets towards adoption of model-based dose calculations for permanent implant prostate brachytherapy

  • Akbari, Fatemeh
  • Peppa, Vasiliki
  • Ouellet, Samuel
  • Moghadam, Narjes
  • Beaulieu, Luc
  • Vijande, Javier
  • Thomson, Rowan M.
  • Oliver-Gil, Sandra|||0000-0001-8258-3972
  • Giménez-Alventosa, Vicent|||0000-0003-1646-6094
[EN] Purpose: This work aims to create and validate a comprehensive set of test cases and 3D reference dosimetric datasets for model-based dose calculation algorithms (MBDCAs) in permanent implant prostate brachytherapy. These test cases address the limits of the standard TG-43 formalism towards improving dose evaluations in prostate cancer treatment, in accordance with the recommendations of the joint Task Group 186 of the American Association of Physicists in Medicine (AAPM), the European Society for Radiotherapy and Oncology (ESTRO), and the Australasian Brachytherapy Group (ABG). Acquisition and validation methods: Six test scenarios using the I-125 OncoSeed 6711 were simulated with three Monte Carlo codes: EGSnrc application egs_brachy with eb_gui, MCNP with BrachyGuide, and PenRed. The test cases range from basic, e.g., single seed in water, to more complex configurations, e.g., 58 seeds in a virtual patient model for prostate treatment. The virtual model was developed from anonymized CT-based images, representing a real patient with and without calcifications. Dose comparisons were performed using both local and global metrics, with eb_gui as the reference for validation. For all test cases, the local agreement of Monte Carlo codes was within ~3.0% and the global agreement was 0.01%. Data format and usage notes: The dataset, including Monte Carlo input files and other required information, is available online at https://doi.org/10.5281/zenodo.15282647. Potential applications: The developed test cases provide an essential resource for the development, validation, and commissioning of MBDCAs. They have the potential to improve dosimetric accuracy in complex prostate implants while also providing a platform for future brachytherapy research., The authors acknowledge support from the Canadian Institutes for Health Research (CIHR) [RMT and LB, funding reference number 437591], Natural Sciences and Engineering Research Council of Canada (NSERC) [RMT, funding reference number 2024-05355], Canada Research Chairs (CRC) program (RMT), the Carleton University Research Office, the Conselleria de Educacion, Universidades y Empleo (GVA), grant CIPROM/2021/64, and the Grant PID2021-125096NB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and by "ERDF A way of making Europe" by the "European Union NextGenerationEU/PRTR", and the IRAMED (CIPROM/2022/38) from "Conselleria d'Innovacio, Universitats, Ciencia i Societat Digital" funded by "Generalitat Valenciana", under the program PROMETEO 2023.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Monte Carlo flattening filter design to high energy intraoperative electron beam homogenization

  • Oliver-Gil, Sandra|||0000-0001-8258-3972
  • Miró Herrero, Rafael|||0000-0003-1012-0869
  • Juste-Vidal, Belen-Jeanne|||0000-0003-1978-3765
  • Verdú Martín, Gumersindo Jesús|||0000-0001-5098-080X
  • Vijande, J.
  • Tejedor-Aguilar, N.
  • Rovira-Escutia, Juan J.
  • Ballester, F.
  • Carmona, V.
  • Felici, G.
  • Sanchis, E.
  • Conde, A.
  • Perez-Calatayud, J.
[EN] Intraoperative radiotherapy using mobile linear accelerators is used for a wide variety of malignancies. However, when large fields are used in combination with high energies, a deterioration of the flatness dose profile is measured with respect to smaller fields and lower energies. Indeed, for the LIAC HWL of Sordina, this deterioration is observed for the 12 MeV beam combined with 10 cm (or larger) diameter applicator. Aimed to solve this problem, a flattening filter has been designed and validated evaluating the feasibility of its usage at the upper part of the applicator. The design of the filter was based on Monte Carlo simulations because of its accuracy in modeling components of clinical devices, among other purposes. The LIAC 10 cm diameter applicator was modeled and simulated independently by two different research groups using two different MC codes, reproducing the heterogeneity of the 12 MeV energy beam. Then, an iterative process of filter design was carried out. Finally, the MC designed conical filter with the optimal size and height to obtain the desired flattened beam was built in-house using a 3D printer. During the experimental validation of the applicator-filter, percentage depth dose, beam profiles, absolute and peripheral dose measurements were performed to demonstrate the effectiveness of the filter addition in the applicator. These measurements conclude that the beam has been flattened, from 5.9% with the standard configuration to 1.6% for the configuration with the filter, without significant increase of the peripheral dose. Consequently, the new filter-applicator LIAC configuration can be used also in a conventional surgery room. A reduction of 16% of the output dose and a reduction of 1.1 mm in the D50 of the percentage depth dose was measured with respect to the original configuration. This work is a proof-of-concept that demonstrates that it is possible to add a filter able to flatten the beam delivered by the Sordina LIAC HWL. Future studies will focus on more refined technical solutions fully compatible with the integrity of the applicator, including its sterilization, to be safely introduced in the clinical practice., The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Giuseppe Felici reports a relationship with S.I.T. Sordina IORT Technologies S.p.A. that includes: employment. We thank the professionals and facilities at the 3D printing and metrology department in the Mechanics Unit at IFIC. JV thanks I. Diaz for measuring the PLA density. We thank S.I.T. SORDINA IORT Tech-nologies SpA for providing the applicator used for testing the filter during the measurements. JV, FB, and JP would like to acknowledge the Spanish "Ministerio de Ciencia e Innovacion" (MCIN) grant PID2021-125096NB-I00 funded by MCIN/AEI/10.13039 and the "Generalitat Valenciana" (GVA) grant PROMETEO/2021/064.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Benchmark of the PenRed Monte Carlo framework for HDR brachytherapy

  • Oliver, Sandra
  • Giménez Alventosa, Vicent
  • Berumen, Francisco
  • Giménez Gómez, Vicente
  • Beaulieu, Luc
  • Ballester, Facundo
  • Vijande, Javier
Purpose: The purpose of this study is to validate the PenRed Monte Carlo framework for clinical applications in brachytherapy. PenRed is a C++ version of Penelope Monte Carlo code with additional tallies and utilities. Methods and materials: Six benchmarking scenarios are explored to validate the use of PenRed and its improved bachytherapy-oriented capabilities for HDR brachytherapy. A new tally allowing the evaluation of collisional kerma for any material using the track length kerma estimator and the possibility to obtain the seed positions, weights and directions processing directly the DICOM file are now implemented in the PenRed distribution. The four non-clinical test cases developed by the Joint AAPM-ESTRO-ABG-ABS WG-DCAB were evaluated by comparing local and global absorbed dose differences with respect to established reference datasets. A prostate and a palliative lung cases, were also studied. For them, absorbed dose ratios, global absorbed dose differences, and cumulative dose-volume histograms were obtained and discussed. Results: The air-kerma strength and the dose rate constant corresponding to the two sources agree with the reference datatests within 0.3% (S) and 0.1% (Λ). With respect to the first three WG-DCAB test cases, more than 99.8% of the voxels present local (global) differences within ±1%(±0.1%) of the reference datasets. For test Case 4 reference dataset, more than 94.9%(97.5%) of voxels show an agreement within ±1%(±0.1%), better than similar benchmarking calculations in the literature. The track length kerma estimator scorer implemented increases the numerical efficiency of brachytherapy calculations two orders of magnitude, while the specific brachytherapy source allows the user to avoid the use of error-prone intermediate steps to translate the DICOM information into the simulation. In both clinical cases, only minor absorbed dose differences arise in the low-dose isodoses. 99.8% and 100% of the voxels have a global absorbed dose difference ratio within ±0.2% for the prostate and lung cases, respectively. The role played by the different segmentation and composition material in the bone structures was discussed, obtaining negligible absorbed dose differences. Dose-volume histograms were in agreement with the reference data. Conclusions: PenRed incorporates new tallies and utilities and has been validated for its use for detailed and precise high-dose-rate brachytherapy simulations., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A User-Friendly System for Mailed Dosimetric Audits of 192Ir or 60Co HDR Brachytherapy Sources

  • Oliver-Cañamás, Laura
  • Vijande, Javier
  • Candela-Juan, Cristian
  • Gimeno-Olmos, José
  • Pujades-Claumarchirant, M.C.
  • Rovira-Escutia, J.J.
  • Ballester, Facundo
  • Perez-Calatayud, José
Objectives: The main goal of this work is to design and characterize a user-friendly methodology to perform mailed dosimetric audits in high dose rate (HDR) brachytherapy for systems using either Iridium-192 (Ir) or Cobalt-60 (Co) sources. Methods: A solid phantom was designed and manufactured with four catheters and a central slot to place one dosimeter. Irradiations with an Elekta MicroSelectron V2 for Ir, and with a BEBIG Multisource for Co were performed for its characterization. For the dose measurements, nanoDots, a type of optically stimulated luminescent dosimeters (OSLDs), were characterized. Monte Carlo (MC) simulations were performed to evaluate the scatter conditions of the irradiation set-up and to study differences in the photon spectra of different Ir sources (Microselectron V2, Flexisource, BEBIG Ir2.A85-2 and Varisource VS2000) reaching the dosimeter in the irradiation set-up. Results: MC simulations indicate that the surface material on which the phantom is supported during the irradiations does not affect the absorbed dose in the nanoDot. Generally, differences below 5% were found in the photon spectra reaching the detector when comparing the Microselectron V2, the Flexisource and the BEBIG models. However, differences up to 20% are observed between the V2 and the Varisource VS2000 models. The calibration coefficients and the uncertainty in the dose measurement were evaluated. Conclusions: The system described here is able to perform dosimetric audits in HDR brachytherapy for systems using either Ir or Co sources. No significant differences are observed between the photon spectra reaching the detector for the MicroSelectron V2, the Flexisource and the BEBIG Ir sources. For the Varisource VS2000, a higher uncertainty is considered in the dose measurement to allow for the nanoDot response., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Monte Carlo flattening filter design to high energy intraoperative electron beam homogenization

  • Oliver, Sandra
  • Vijande, Javier
  • Tejedor-Aguilar, N.
  • Miró, R.
  • Rovira-Escutia, J.J.
  • Ballester, Facundo
  • Juste, B.
  • Carmona, Valentina
  • Felici, Giuseppe
  • Verdú, Gumersindo
  • Sanchis, Enrique
  • Conde Moreno, Antonio José
  • Pérez-Calatayud, J.
Intraoperative radiotherapy using mobile linear accelerators is used for a wide variety of malignancies. However, when large fields are used in combination with high energies, a deterioration of the flatness dose profile is measured with respect to smaller fields and lower energies. Indeed, for the LIAC HWL of Sordina, this deterioration is observed for the 12 MeV beam combined with 10 cm (or larger) diameter applicator. Aimed to solve this problem, a flattening filter has been designed and validated evaluating the feasibility of its usage at the upper part of the applicator. The design of the filter was based on Monte Carlo simulations because of its accuracy in modeling components of clinical devices, among other purposes. The LIAC 10 cm diameter applicator was modeled and simulated independently by two different research groups using two different MC codes, reproducing the heterogeneity of the 12 MeV energy beam. Then, an iterative process of filter design was carried out. Finally, the MC designed conical filter with the optimal size and height to obtain the desired flattened beam was built in-house using a 3D printer. During the experimental validation of the applicator-filter, percentage depth dose, beam profiles, absolute and peripheral dose measurements were performed to demonstrate the effectiveness of the filter addition in the applicator. These measurements conclude that the beam has been flattened, from 5.9% with the standard configuration to 1.6% for the configuration with the filter, without significant increase of the peripheral dose. Consequently, the new filter-applicator LIAC configuration can be used also in a conventional surgery room. A reduction of 16% of the output dose and a reduction of 1.1 mm in the D of the percentage depth dose was measured with respect to the original configuration. This work is a proof-of-concept that demonstrates that it is possible to add a filter able to flatten the beam delivered by the Sordina LIAC HWL. Future studies will focus on more refined technical solutions fully compatible with the integrity of the applicator, including its sterilization, to be safely introduced in the clinical practice., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

A MC-based anthropomorphic test case for commissioning model-based dose calculation in interstitial breast 192-Ir HDR brachytherapy

  • Peppa, Vasiliki
  • Thomson, Rowan M.
  • Enger, Shirin A.
  • Fonseca, Gabriel P.
  • Lee, Choonik
  • Lucero, Joseph N. E.
  • Mourtada, Firas
  • Siebert, Frank-André
  • Vijande, Javier
  • Papagiannis, Panagiotis
Purpose: To provide the first clinical test case for commissioning of Ir brachytherapy model-based dose calculation algorithms (MBDCAs) according to the AAPM TG-186 report workflow. Acquisition and Validation Methods: A computational patient phantom model was generated from a clinical multi-catheter Ir HDR breast brachytherapy case. Regions of interest (ROIs) were contoured and digitized on the patient CT images and the model was written to a series of DICOM CT images using MATLAB. The model was imported into two commercial treatment planning systems (TPSs) currently incorporating an MBDCA. Identical treatment plans were prepared using a generic Ir HDR source and the TG-43-based algorithm of each TPS. This was followed by dose to medium in medium calculations using the MBDCA option of each TPS. Monte Carlo (MC) simulation was performed in the model using three different codes and information parsed from the treatment plan exported in DICOM radiation therapy (RT) format. Results were found to agree within statistical uncertainty and the dataset with the lowest uncertainty was assigned as the reference MC dose distribution. Data Format and Usage Notes: The dataset is available online at http://irochouston.mdanderson.org/rpc/BrachySeeds/BrachySeeds/index.html,https://doi.org/10.52519/00005. Files include the treatment plan for each TPS in DICOM RT format, reference MC dose data in RT Dose format, as well as a guide for database users and all files necessary to repeat the MC simulations. Potential Applications: The dataset facilitates the commissioning of brachytherapy MBDCAs using TPS embedded tools and establishes a methodology for the development of future clinical test cases. It is also useful to non-MBDCA adopters for intercomparing MBDCAs and exploring their benefits and limitations, as well as to brachytherapy researchers in need of a dosimetric and/or a DICOM RT information parsing benchmark. Limitations include specificity in terms of radionuclide, source model, clinical scenario, and MBDCA version used for its preparation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

AAPM WGDCAB Report 372: A joint AAPM, ESTRO, ABG, and ABS report on commissioning of model-based dose calculation algorithms in brachytherapy

  • Beaulieu, Luc
  • Ballester, Facundo
  • Granero, Domingo
  • Tedgren, Åsa Carlsson
  • Haworth, Annette
  • Jessica R. Lowenstein,
  • Ma, Yunzhi
  • Mourtada, Firas
  • Papagiannis, Panagiotis
  • Rivard, Mark J.
  • Siebert, Frank-André
  • Sloboda, Ron S.
  • Thomson, Rowan M.
  • Verhaegen, Frank
  • Fonseca, Gabriel
  • Vijande, Javier
The introduction of model-based dose calculation algorithms (MBDCAs) in brachytherapy provides an opportunity for a more accurate dose calculation and opens the possibility for novel, innovative treatment modalities. The joint AAPM, ESTRO, and ABG Task Group 186 (TG-186) report provided guidance to early adopters. However, the commissioning aspect of these algorithms was described only in general terms with no quantitative goals. This report, from the Working Group on Model-Based Dose Calculation Algorithms in Brachytherapy, introduced a field-tested approach to MBDCA commissioning. It is based on a set of well-characterized test cases for which reference Monte Carlo (MC) and vendor-specific MBDCA dose distributions are available in a Digital Imaging and Communications in Medicine—Radiotherapy (DICOM-RT) format to the clinical users. The key elements of the TG-186 commissioning workflow are now described in detail, and quantitative goals are provided. This approach leverages the well-known Brachytherapy Source Registry jointly managed by the AAPM and the Imaging and Radiation Oncology Core (IROC) Houston Quality Assurance Center (with associated links at ESTRO) to provide open access to test cases as well as step-by-step user guides. While the current report is limited to the two most widely commercially available MBDCAs and only for Ir-based afterloading brachytherapy at this time, this report establishes a general framework that can easily be extended to other brachytherapy MBDCAs and brachytherapy sources. The AAPM, ESTRO, ABG, and ABS recommend that clinical medical physicists implement the workflow presented in this report to validate both the basic and the advanced dose calculation features of their commercial MBDCAs. Recommendations are also given to vendors to integrate advanced analysis tools into their brachytherapy treatment planning system to facilitate extensive dose comparisons. The use of the test cases for research and educational purposes is further encouraged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dosimetry audits in high dose rate brachytherapy: A survey on the current scenario in Europe

  • Oliver-Cañamás, Laura
  • Vijande, Javier
  • Candela-Juan, Cristian
  • Perez-Calatayud, Jose
This work aims to study the current scenario of dosimetry audits in high dose rate (HDR) brachytherapy (BT) in Europe to evaluate whether there is a need to implement more services of this type and to define the characteristics that they should meet according to users., Funding from the Conselleria de Educación, Universidades y Empleo (GVA), grant CIPROM/2021/64, the Grant PID2021-125096NB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” by the “European Union NextGenerationEU/PRTR,” is acknowledged., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Dosimetric impact of physics libraries for electronic brachytherapy Monte Carlo studies

  • Valdes-Cortez, Christian
  • Mansour, Iymad
  • Ayala Alvarez, David Santiago
  • Berumen, Francisco
  • Côte, Jean-Simon
  • Ndoutoume-Paquet, Gaël
  • Watson, Peter G F
  • Seuntjens, Jan
  • Ballester, Facundo
  • Mainegra-Hing, Ernesto
  • Thomson, Rowan M
  • Beaulieu, Luc
  • Vijande, Javier
A Correction to this article was published on june 2025: http://hdl.handle.net/10261/431021, Low-energy x-ray beams used in electronic brachytherapy (eBT) present significant dosimetric challenges due to their high depth-dose gradients, the dependence of detector response on materials, and the lack of standardized dose-to-water references. These challenges have driven the need for Monte Carlo (MC) simulations to ensure accurate dosimetry. However, discrepancies in the physics models used by different MC systems have raised concerns about their dosimetric consistency, particularly in modeling bremsstrahlung interactions., Javier Vijande and Facundo Ballester acknowledge the Conselleria de Educación, Universidades y Empleo (GVA), grant CIPROM/2021/64, the Grant PID2021-125096NB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” by the “European Union NextGenerationEU/PRTR,” and JCyL grant SA091P24 under program EDU/841/2024. Luc Beaulieu, Rowan M. Thomson, and Iymad Mansour acknowledge support from the Natural Sciences and Engineering Research Council (NSERC) of Canada (funding reference numbers RGPIN 2019–05038 [Luc Beaulieu], RGPIN-2024-05355 [Rowan M. Thomson], and 546549-2020 [Iymad Mansour]). Rowan M. Thomson acknowledges support from the Canada Research Chairs program. Iymad Mansour acknowledges support from the Kiwanis Club of Ottawa Medical Foundation and Dr. Kanta Marwah Scholarship in Medical Physics. David Santiago Ayala Alvarez acknowledges the financial support from the Fonds de Recherche du Québec—Santé (FRQS, grant number 292924). Jan Seuntjens and David Santiago Ayala Alvarez were funded by grants from the Canadian Institutes of Health Research (CIHR, Foundation grant number FDN-143257) and the NSERC (grant number RGPIN-2019-06746)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Reference datasets for commissioning of model-based dose calculation algorithms for electronic brachytherapy

  • Mansour, Iymad R
  • Valdes-Cortez, Christian
  • Ayala Alvarez, David Santiago
  • Berumen, Francisco
  • Côte, Jean-Simon
  • Ndoutoume-Paquet, Gaël
  • Watson, Peter G F
  • Seuntjens, Jan
  • Ballester, Facundo
  • Mainegra-Hing, Ernesto
  • Thomson, Rowan M
  • Beaulieu, Luc
  • Vijande, Javier
Purpose: This work provides the first two clinical test cases for commissioning electronic brachytherapy (eBT) model-based dose calculation algorithms (MBDCAs) for skin irradiation using surface applicators. Acquisition and Validation Methods: The test cases utilize the INTRABEAM 30 mm surface applicator. Test Case I: water phantom is used to evaluate the algorithm's performance in a uniform medium consisting of a voxelized water cube surrounded by air. Test Case II: Surface eBT represents a heterogeneous medium with four distinct layers: skin tissue, adipose tissue, cortical bone, and soft tissue. Treatment plans for both cases were created and exported into the Radiance treatment planning system (TPS). Dose-to-medium calculations were then performed using this Monte Carlo (MC)-based TPS and compared with MC simulations conducted independently by three different groups using two codes: EGSnrc and PENELOPE. The results agreed within expected Type A and B statistical uncertainties. Data Format and Usage Notes: The dataset is available online at https://doi.org/10.52519/00005. A proprietary file designed for use within Radiance containing CT images and the treatment plan for both test cases, the LINAC modeling, and the CT calibration are included, as well as reference MC and TPS dose data in RTdose format and all files required to run the MC simulations. Potential Applications: This dataset serves as a valuable resource for commissioning eBT MBDCAs and lays the groundwork for developing clinical test cases for other eBT systems. It is also a helpful educational tool for exploring various eBT devices and their advantages and drawbacks. Furthermore, brachytherapy researchers seeking a benchmark for dosimetric calculations in the low-energy domain will find this dataset indispensable., Conselleria de Educación, Universidades y Empleo (GVA). Grant Number: CIPROM/2021/64MCIN AEI “ERDF A way of making Europe” by the “European Union NextGenerationEU/PRTR”. Grant Number: PID2021-125096NB-I00 JCyL. Grant Number: SA091P24 Fonds de Recherche du Québec—Santé. Grant Number: 292924 Canadian Institutes of Health Research. Grant Number: FDN-143257 Natural Sciences and Engineering Research Council. Grant Numbers: RGPIN2019–05038, RGPIN-2024-05355, 546549-2020, RGPIN-2019-06746, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Head and neck and skin (HNS) GEC-ESTRO and BRAPHYQS working groups joint critical review of the use of Rhenium-188 in dermato-oncology

  • Lozares, Sergio
  • Tur, Paula
  • Ballester, Facundo
  • Bundschuh, Ralph Alexander
  • González-Pérez, Víctor
  • Jaberi, Ramin
  • Vijande, Javier
  • Walter, Renate
  • Tedgren, Åsa Carlsson
  • Tagliaferri, Luca
  • Siebert, Frank-André
  • Rembielak, Agata
Non-melanoma skin cancers are increasing globally, prompting the need for innovative, non-invasive treatment approaches. Radioactive rhenium (188Re) paste has emerged as an open-source radiation-based modality in dermato-oncology, offering a novel alternative to conventional radiotherapy and brachytherapy. In this review, a systematic literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar for studies published over the past 20 years. Data were extracted from case series, pilot studies, and clinical trials, with particular emphasis on response rates, dosimetric parameters, and treatment-associated toxicity. Findings from approximately 240 patients demonstrated complete response rates ranging from 86 % to 100 % after one or two treatment applications, while dosimetric analyses revealed a rapid dose fall-off that effectively confines the therapeutic effect to a tissue depth of 2-3  mm, with most adverse effects being mild and transient. Notably, 188Re differs from conventional brachytherapy (specifically high-dose-rate modality) due to its open-source application and unique dosimetric profile. The use of 188Re in clinical practice mandates a highly specialized, multidisciplinary team, including radiation oncologists, nuclear medicine specialists, and experienced medical physicists, and strict quality assurance protocols, thereby limiting its application to carefully selected cases. Although 188Re therapy offers a promising alternative for the treatment of superficial skin cancers, its distinct clinical and dosimetric characteristics warrant further randomized studies with extended follow-up to validate its efficacy and refine patient selection criteria under rigorous multidisciplinary oversight., JV acknowledges the Conselleria de Educación, Universidades y Empleo (GVA), grant CIPROM/2021/64, the Grant PID2021-125096NB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” by the “European Union NextGenerationEU/PRTR”., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Generation of 3D reference dosimetric datasets towards adoption of model-based dose calculations for permanent implant prostate brachytherapy

  • Akbari, Fatemeh
  • Peppa, Vasiliki
  • Ouellet, Samuel
  • Moghadam, Narjes
  • Oliver, Sandra
  • Giménez Alventosa, Vicent
  • Beaulieu, Luc
  • Vijande, Javier
  • Thomson, Rowan M
This work aims to create and validate a comprehensive set of test cases and 3D reference dosimetric datasets for model-based dose calculation algorithms (MBDCAs) in permanent implant prostate brachytherapy. These test cases address the limits of the standard TG-43 formalism towards improving dose evaluations in prostate cancer treatment, in accordance with the recommendations of the joint Task Group 186 of the American Association of Physicists in Medicine (AAPM), the European Society for Radiotherapy and Oncology (ESTRO), and the Australasian Brachytherapy Group (ABG)., The authors acknowledge support from the Canadian Institutes for Health Research (CIHR) [RMT and LB, funding reference number 437591], Natural Sciences and Engineering Research Council of Canada (NSERC) [RMT, funding reference number 2024-05355], Canada Research Chairs (CRC) program (RMT), the Carleton University Research Office, the Conselleria de Educación, Universidades y Empleo (GVA), grant CIPROM/2021/64, and the Grant PID2021-125096NB-I00 funded by MCIN/AEI/ 10.13039/501100011033 and by “ERDF A way of making Europe” by the “European Union NextGenerationEU/PRTR”, and the IRAMED (CIPROM/2022/38) from “Conselleria d'Innovació, Universitats, Ciència i Societat Digital” funded by “Generalitat Valenciana”, under the program PROMETEO 2023., Peer reviewed